Also trades as: 0VGI.L (LSE) · $vol 0M
TGTX NASDAQ
TG Therapeutics, Inc.
1W: -3.8%
1M: +2.4%
3M: +32.9%
YTD: +34.0%
1Y: +10.6%
3Y: +29.1%
5Y: +14.5%
$38.87
-0.37 (-0.94%)
Weekly Expected Move ±10.5%
$31
$35
$40
$44
$48
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$700M
Revenue
+81.3% YoY
$462M
Net Income
+1079.8% YoY
$-14M
Free Cash Flow
+76.8% YoY
83.6%
Gross Margin
17.0%
Op. Margin
9.7%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE106.1%
ROA56.3%
ROIC73.6%
Valuation
P/E12.2
P/B9.6
EV/EBITDA34.7
Leverage
Debt/Equity0.40
Current Ratio4.10
Interest Cov.5.7x
Quality Scores
Piotroski F5/9
Altman Z7.94
Beneish M22.77